BERNINI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 17.772
AS - Asia 15.157
EU - Europa 9.641
SA - Sud America 2.127
AF - Africa 725
Continente sconosciuto - Info sul continente non disponibili 585
OC - Oceania 14
Totale 46.021
Nazione #
US - Stati Uniti d'America 17.241
SG - Singapore 5.592
CN - Cina 4.045
VN - Vietnam 2.247
IE - Irlanda 1.639
BR - Brasile 1.607
IT - Italia 1.416
FI - Finlandia 1.293
DE - Germania 1.211
HK - Hong Kong 1.208
SE - Svezia 1.165
UA - Ucraina 917
FR - Francia 568
ZA - Sudafrica 560
TR - Turchia 557
BD - Bangladesh 489
NL - Olanda 455
GB - Regno Unito 314
CA - Canada 304
RU - Federazione Russa 206
AR - Argentina 192
IN - India 191
AT - Austria 106
IQ - Iraq 104
CO - Colombia 101
JP - Giappone 98
MX - Messico 95
ID - Indonesia 86
KR - Corea 78
EC - Ecuador 74
PH - Filippine 68
PL - Polonia 61
ES - Italia 56
VE - Venezuela 53
BE - Belgio 52
CZ - Repubblica Ceca 48
TH - Thailandia 48
PK - Pakistan 45
UZ - Uzbekistan 38
PY - Paraguay 32
MA - Marocco 31
TW - Taiwan 31
SA - Arabia Saudita 29
MY - Malesia 25
EG - Egitto 24
CL - Cile 22
KE - Kenya 22
AE - Emirati Arabi Uniti 21
CI - Costa d'Avorio 19
JM - Giamaica 19
JO - Giordania 19
CR - Costa Rica 18
AL - Albania 17
IL - Israele 17
PE - Perù 17
KZ - Kazakistan 16
UY - Uruguay 16
EU - Europa 15
LT - Lituania 15
TT - Trinidad e Tobago 14
DZ - Algeria 13
IR - Iran 13
TN - Tunisia 13
HN - Honduras 12
OM - Oman 12
RO - Romania 12
AU - Australia 11
PA - Panama 11
ET - Etiopia 10
NP - Nepal 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
LB - Libano 9
AZ - Azerbaigian 8
BB - Barbados 8
BG - Bulgaria 8
EE - Estonia 8
HU - Ungheria 8
KG - Kirghizistan 8
NI - Nicaragua 8
PR - Porto Rico 8
BY - Bielorussia 7
GT - Guatemala 7
MD - Moldavia 7
PT - Portogallo 7
RS - Serbia 7
SV - El Salvador 7
SY - Repubblica araba siriana 7
KW - Kuwait 6
QA - Qatar 6
BH - Bahrain 5
CH - Svizzera 5
LU - Lussemburgo 5
PS - Palestinian Territory 5
SN - Senegal 5
GR - Grecia 4
MK - Macedonia 4
NG - Nigeria 4
AM - Armenia 3
AO - Angola 3
Totale 45.379
Città #
Singapore 2.626
San Jose 1.866
Ashburn 1.721
Dublin 1.639
Chandler 1.552
Hong Kong 1.134
Jacksonville 1.121
Santa Clara 1.119
Beijing 1.079
Council Bluffs 684
Ho Chi Minh City 684
Dallas 632
Boardman 537
Johannesburg 526
Hanoi 509
Nanjing 508
Dearborn 499
Izmir 485
New York 435
Princeton 388
Ann Arbor 376
Lauterbourg 361
Parma 327
Los Angeles 306
Wilmington 263
Munich 245
San Mateo 234
Bremen 230
Hefei 180
Helsinki 179
Toronto 175
Shanghai 165
Shenyang 154
São Paulo 149
Nanchang 137
Hebei 134
Moscow 126
Buffalo 125
Kunming 118
Columbus 111
Seattle 101
Jinan 98
Des Moines 97
Haiphong 97
Milan 96
Tianjin 94
Vienna 91
Da Nang 86
Chicago 83
Jiaxing 78
Rome 78
Woodbridge 75
Grafing 73
Changsha 71
Guangzhou 63
Marseille 59
Houston 57
Norwalk 57
Tokyo 57
Seoul 55
Atlanta 54
Brooklyn 54
Orem 53
Brussels 49
The Dalles 48
Bologna 47
Montreal 47
Phoenix 47
Warsaw 47
Zhengzhou 47
Hải Dương 46
Turku 44
Rio de Janeiro 41
Frankfurt am Main 40
Biên Hòa 39
Pune 39
Belo Horizonte 38
Washington 38
Baghdad 37
Bogotá 37
North Bergen 37
Denver 35
Hangzhou 35
San Francisco 34
Chennai 33
Tashkent 33
Jakarta 32
Brasília 30
Modena 30
Fremont 29
Brno 28
Guayaquil 27
Curitiba 26
London 26
Mexico City 26
Naples 26
Ninh Bình 26
Nuremberg 26
Taiyuan 26
Quito 25
Totale 26.887
Nome #
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 359
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 319
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 266
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 248
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 245
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 242
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis 230
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 226
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 222
Biocompatible 3d printed chitosan-based scaffolds containing α-tocopherol showing antioxidant and antimicrobial activity 219
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects 212
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum 199
Advance diagnostic support in lipidology project: role for phenotipic and functional evaluation of lipoproteins in dyslipidemias 189
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 187
Highly defined 3D printed chitosan scaffolds featuring improved cell growth 187
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 186
Antiatherogenic effects of ellagic acid and urolithins in vitro 184
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 182
Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study 181
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 176
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 175
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 175
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 175
Cholesterol efflux and reverse cholesterol transport 174
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 173
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 171
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 171
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 169
The natural compound berberine positively affects macrophage functions involved in atherogenesis 169
Assessment of Cholesterol Efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate 168
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 168
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 165
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 165
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL 163
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 161
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 161
Study of 3D-printed chitosan scaffold features after different post-printing gelation processes 161
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women 161
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 160
EFFECT OF VITAMIN D REPLACEMENT ON SERUM LIPOPROTEIN FUNCTIONALITY IN HEALTHY PRE-MENOPAUSAL WOMEN 159
CHARACTERIZATION OF THREE KINDRED WITH FAMILIAL COMBINED HYPOLIPIDEMIA DUE TO LOSS OF FUNCTION MUTATIONS OF ANGPTL3 159
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFFNESS IN HEALTHY SUBJECTS 158
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 157
Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein 157
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 156
A NOVEL MUTATION IN CETP GENE AS A CAUSE OF CETP DEFICIENCY IN A CAUCASIAN KINDRED 155
Probucol inhibits ABCA1-mediated cellular lipids efflux 154
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 154
Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation. 154
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 153
New MDR1 inhibitors for overcoming multidrug resistance 153
6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells. 153
5,6-diphenylpyridazine derivatives as acyl-Coacholesterol acyltransferase inhibitors 152
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 152
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 151
Role of Apolipoprotein E in cellular cholesterol efflux 150
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 149
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 149
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 149
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women 149
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 148
CHOLESTEROL EFFLUX AND CHOLESTEROL LOADING CAPACITY OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 148
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 148
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 148
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 147
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 147
Natural anti-endothelial cell antibodies (AECA) 146
Cholesterol efflux capacity of sera from subjects with LCAT deficiency 145
Cholesterol efflux potential of sera from subjects with LCAT deficiency 144
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 143
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 143
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 143
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 143
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 142
Hydrocortisone directly promotes cholesterol accumulation in macrophages. 142
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 140
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 140
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability and telomere length in healthy octogenarians 139
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 139
Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv®, in a Hypercholesterolemia-Induced Golden Syrian Hamster Model 139
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 138
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM DIABETIC PATIENTS: CLINICAL APPLICATIONS 138
An w-3 polyunsaturated fatty acid concentrate increases plasma HDL2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia 137
Increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia 137
27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells 137
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women 136
ANTIATHEROSCLEROTIC EFFECTS OF A NEW COMBINATION OF BERBERINE, MONACOLIN K AND MORUS ALBA: IMPROVEMENT OF HDL FUNCTION 136
Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA) 136
The c-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phopspholipid and cholesterol efflux 135
New insights into the pharmacodynamic and pharmacokinetic properties of statins 135
New mechanisms for steroid pro-atherogenic action: up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracelluar cholesterol stores. 135
Effects of a new combination of Berberine, Monacolin k and Morus Alba on lipid profile and HDL functions in healty subjects: a pilot study 135
High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. 135
A BENZODIAZEPINE ANALOGUE PROMOTES FAECAL STEROL EXCRETION IN APOA-I OVEREXPRESSING MICE 134
Cholesterol efflux capacity and arterial stiffness: data from the brisighella heart study 134
A novel homozigous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 133
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFNESS IN HEALTY SUBJECTS 133
Natural anti-endothelial cell antibodies (AECA) 132
Attivita’ del probucolo nell’inibire l’efflusso lipidico cellulare ABCA1 mediato 132
Evaluation of HDL cholesterol efflux capacity (CEC) after consumption of an innovative pasta enriched with bioactive components and functional probiotics 132
Totale 16.441
Categoria #
all - tutte 169.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.518 0 0 0 58 36 95 185 211 92 151 81 609
2022/20236.014 702 447 306 439 738 672 54 332 2.042 42 177 63
2023/20242.168 126 244 66 73 151 603 122 157 49 82 157 338
2024/20257.487 137 454 533 428 762 711 229 336 966 732 582 1.617
2025/202616.178 1.262 1.575 1.738 1.283 2.356 806 2.129 573 2.098 1.181 684 493
2026/20273.216 504 826 893 993 0 0 0 0 0 0 0 0
Totale 46.021